2.4999
1.19%
-0.0301
Aditxt Inc stock is currently priced at $2.4999, with a 24-hour trading volume of 33,503.
It has seen a -1.19% decreased in the last 24 hours and a -19.49% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $2.50 pivot point. If it approaches the $2.72 resistance level, significant changes may occur.
Previous Close:
$2.53
Open:
$2.46
24h Volume:
33,503
Market Cap:
$4.21M
Revenue:
$749.50K
Net Income/Loss:
$-29.60M
P/E Ratio:
-0.00665
EPS:
-376.0263
Net Cash Flow:
$-22.09M
1W Performance:
+6.38%
1M Performance:
-19.49%
6M Performance:
-65.28%
1Y Performance:
-90.08%
Aditxt Inc Stock (ADTX) Company Profile
Name
Aditxt Inc
Sector
Industry
Phone
909 488 0844
Address
737 North Fifth Street, Suite 200, Richmond
Aditxt Inc Stock (ADTX) Latest News
Why Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Longboard Pharmaceuticals Shares Are Trading Higher By Around 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why LumiraDx Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
US Stocks Edge Higher On Last Trading Day Of 2023; Chicago PMI Falls In December
Benzinga
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Benzinga
Aditxt Inc Stock (ADTX) Financials Data
Aditxt Inc (ADTX) Revenue 2024
ADTX reported a revenue (TTM) of $749.50 thousand for the quarter ending September 30, 2023, a -12.15% decline year-over-year.
Aditxt Inc (ADTX) Net Income 2024
ADTX net income (TTM) was -$29.60 million for the quarter ending September 30, 2023, a +31.99% increase year-over-year.
Aditxt Inc (ADTX) Cash Flow 2024
ADTX recorded a free cash flow (TTM) of -$22.09 million for the quarter ending September 30, 2023, a +10.77% increase year-over-year.
Aditxt Inc (ADTX) Earnings per Share 2024
ADTX earnings per share (TTM) was -$214.00 for the quarter ending September 30, 2023, a +88.26% growth year-over-year.
About Aditxt Inc
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
Cap:
|
Volume (24h):